Magnesium Citrate Saline Laxative - Lemon Flavor

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within ½ to 6 hours of administration.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose. The medication may be administered as a single daily dose or divided into multiple doses throughout the day.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period. For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period. For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period. For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of an overdose, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

Healthcare professionals should exercise caution when recommending this product. Prior to use, it is imperative to consult a physician if the patient has any of the following conditions:

• Kidney disease

• A magnesium-restricted diet

• Symptoms such as abdominal pain, nausea, or vomiting

• A sudden change in bowel habits that persists for more than two weeks

• A history of laxative use exceeding one week

Additionally, it is advisable to consult a doctor or pharmacist if the patient is currently taking any other medications. This product should be administered at least two hours before or after other drugs, as laxatives may influence the efficacy of concurrent medications.

Patients should discontinue use and seek medical advice if they experience rectal bleeding or fail to have a bowel movement after using the product, as these symptoms may indicate a serious underlying condition.

For pregnant or breastfeeding individuals, it is essential to consult a healthcare professional before use to ensure safety for both the mother and child.

In the event of an overdose, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this product. Serious adverse reactions may include rectal bleeding or failure to have a bowel movement after use, which could indicate a serious underlying condition. In such cases, patients are advised to stop use and consult a doctor immediately.

Additional considerations are necessary for patients with specific health conditions. Individuals with kidney disease, those on a magnesium-restricted diet, or patients experiencing abdominal pain, nausea, or vomiting should seek medical advice before using this product. Furthermore, a sudden change in bowel habits that persists for more than two weeks or the prolonged use of a laxative for more than one week warrants consultation with a healthcare professional.

Patients taking other medications should also consult a doctor or pharmacist prior to use, as laxatives may influence the efficacy of other drugs. It is recommended that this product be taken at least two hours before or after other medications to minimize potential interactions.

For pregnant or breastfeeding individuals, it is essential to seek guidance from a health professional before using this product to ensure safety for both the patient and the child.

Drug Interactions

The use of this product should be carefully timed in relation to other medications. It is recommended that this product be taken at least 2 hours before or after the administration of other drugs. This precaution is particularly important as laxatives may influence the efficacy of concurrent medications.

Currently, there is no specific information available regarding drug interactions or interactions with laboratory tests. Therefore, healthcare professionals should remain vigilant and monitor patients for any potential effects when this product is used in conjunction with other therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Magnesium Citrate Saline Laxative - Lemon Flavor (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a maximum dosage of 7 fluid ounces in a 24-hour period. For children aged 2 to under 6 years, the maximum dosage is 2 to 3 fluid ounces within the same timeframe. It is advised that caregivers consult a physician before administering the product to children under 2 years of age.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment should consult a healthcare professional prior to use, particularly if they have a history of kidney disease. It is essential to assess renal function and consider potential dosing adjustments or monitoring requirements based on the degree of impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with the overdose.

Healthcare professionals should be aware that the specific symptoms of an overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential to determine the appropriate course of action.

Management of an overdose typically involves supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended. In cases where the substance is known, specific antidotes or treatments may be indicated, and healthcare providers should refer to established guidelines for the management of the particular overdose scenario.

It is vital for healthcare professionals to remain vigilant and act swiftly in the event of an overdose to ensure optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event of an overdose, healthcare providers should instruct patients to seek medical help immediately or contact a Poison Control Center. Patients should be made aware of the signs of overdose and the urgency of obtaining assistance to ensure their safety and well-being.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46°F to 86°F (8°C to 30°C) to maintain its efficacy and safety. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

Patients should be informed that the medication is administered orally. Clinicians are advised to counsel patients to consult a doctor before use if they have kidney disease, are on a magnesium-restricted diet, experience abdominal pain, nausea, or vomiting, notice a sudden change in bowel habits lasting more than two weeks, or have used a laxative for longer than one week.

Additionally, patients should be instructed to speak with a doctor or pharmacist if they are taking any other medications, as this product should be taken at least two hours before or after other drugs to avoid potential interactions. Patients must discontinue use and seek medical advice if they experience rectal bleeding or do not have a bowel movement after use, as these may indicate a serious condition. Pregnant or breastfeeding individuals should also consult a healthcare professional prior to use.

Drug Information (PDF)

This file contains official product information for Magnesium Citrate Saline Laxative - Lemon Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)